★
FTRE
Fortrea Holdings Inc · Life Sciences Tools & Services
FCF$190mC
Rev+0.9%C
D/E1.87C
P/S0.5xA
PEG——
69Score
$13.221Y Target$17.85Near-term target
5Y Target$26.59Compound horizon
10Y Target$69.19Long-dated conviction
FCF$190mTTM · 03/26C
FCF $190m — modest; watch for margin expansion · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+0.9%TTM YoYC
Revenue +0.9% — flat, mature phase or headwinds present · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E1.87totalC
D/E 1.87 — elevated leverage, limits flexibility · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/S0.5xA
P/S 0.5x — deep value on sales
PEG—proxy—
PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Life Sciences Tools & Services · market cap $1.3b. Down 29% from 52-week high of $18.67 — deep drawdown territory.
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Currently unprofitable (margin -16.5%) — path to GAAP profitability is the core thesis risk. Beta 2.00 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return. ROE -79% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Horizon
1-3 yr $17.85 (structural (no analyst coverage)) — catalyst-driven; binary events dominate. 5 yr $26.59 — requires the platform / technology to reach commercial scale. 10 yr $69.19 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Position sizing · FTRE
Shares to buy
151
Position size
$1,996
4.0% of portfolio
Stop price
$9.92
25% below $13.22
$ at risk
$500.00
1% of portfolio
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.